S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Here's the sad truth about tax-'inversion' deals (2014/7/18)|
|Abbott Laboratories ABT Announces Acquisition of CFR Pharmaceuticals (2014/9/26)|
|Abbott Labs shares climb 2.7% as profit, sales top estimates|
|Abbott Labs to sell part of generics business for $5.3 billion|
|Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan|
|AbbVie Reports Second-Quarter 2014 Financial Results|
|Enanta Pharmaceuticals Announces Data Presentations on Regimens Containing ABT-450 or ABT-493 to be Presented at the American Association for the Study of Liver Diseases (AASLD)|
|Enanta Pharmaceuticals Announces the Initiation of Phase 2b Clinical Trial with Regimen Containing HCV Protease Inhibitor ABT-493|
|Abbott Joins Forces with U.S. Department of Defense to Develop Portable Blood Tests for Evaluating Concussions|
|AbbVie Receives EMA and FDA Orphan Drug Designation for Investigational Compound ABT-414 in the Treatment of Glioblastoma Multiforme|
Click above to view more mutual fund data and stats for abt - Abbott Laboratories.